Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Jeune Aesthetics, Subsidiary Of Krystal Biotech, Announced Positive Interim Safety And Efficacy Results From Both Cohorts 3 And 4 Of PEARL-1, A Phase 1 Study Evaluating KB301 In The Treatment Of Lateral Canthal Lines And Dynamic Wrinkles Of The Décolleté

Author: Benzinga Newsdesk | August 28, 2024 07:11am

Posted In: KRYS